Heterogeneity and clinical relevance of group 2 innate lymphoid cells subsets in nasal polyps
Journal of Allergy and Clinical Immunology · 2026
DOI: 10.1016/j.jaci.2026.03.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026. Verfasst von Masanori Kidoguchi und 22 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Ill; Division of Otorhinolaryngology and Head & Nec…. Hauptthemen laut MEDLINE: Nasal Polyps, Rhinosinusitis, Lymphocytes, Lymphocyte Subsets. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIH NIAID.
Abstract (Originalsprache)
BACKGROUND: Chronic rhinosinusitis with nasal polyps is characterized by type 2 (T2) inflammation with elevated IL-5 and IL-13. Although group 2 innate lymphoid cells (ILC2s) drive T2 inflammation, their subset diversity and clinical relevance in nasal polyps (NPs) remain unclear. OBJECTIVE: We investigated cellular sources of T2 cytokines, subset heterogeneity of ILC2s, and the relationship between ILC2 subsets and clinical severity in chronic rhinosinusitis with NPs. METHODS: ILC2s and CD4+ T cells were isolated from NP tissue and analyzed for cytokine production. ILC2s from 6 NP and 4 peripheral blood samples underwent single-cell RNA sequencing. Differential gene expression, subset heterogeneity, and pseudotime trajectory analyses were performed. Flow cytometry validated ILC2 subsets and associations with clinical parameters. RESULTS: Under ex vivo conditions, NP-derived ILC2s produced higher IL-5 and IL-13 levels than TH2 cells. NP-derived ILC2s showed downregulation of early developmental and trafficking genes (CD48, S1PR1) and upregulation of T2-associated cytokines (IL5, IL13), chemokines (XCL1, CXCL8), remodeling factors (AREG, TNFSF14), and METRNL. Four ILC2 subsets reflecting activation states were identified: migratory (tissue-homing with less activation), transitional (intermediate activation), inflammatory (high activation and T2 cytokines), and exhausted-like (expression of inhibitory receptors [eg, TIGIT]). The combined number of T2 cytokine-enriched subsets (transitional, inflammatory, and exhausted-like ILC2s) correlated with Lund-Mackay computed tomography scores. Inflammatory and exhausted-like ILC2s were associated with clinical symptom severity. CONCLUSION: ILC2s are one of the important effector populations driving local T2 inflammation in NPs and include 4 subsets with specific clinical associations. Subset-level ILC2 profiling may clarify chronic rhinosinusitis with NP pathophysiology and inform clinical stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Ill; Division of Otorhinolaryngology and Head & Neck Surgery, Department of Sensory and Locomotor Medicine, Faculty of Me…
- Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Ill.
- Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Ill; Department of Otorhinolaryngology, International University of Health and Welfare, Narita, Japan.
- Department of Otorhinolaryngology, International University of Health and Welfare, Narita, Japan.
- Center for Human Immunobiology, Northwestern University Feinberg School of Medicine, Chicago, Ill; Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, Ill.
- Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- NIH NIAID
- National Cancer Institute
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Sanofi US
- Japan Society for the Promotion of Science
- University of California, Los Angeles
Zitieren
APA
Kidoguchi, M., Iwasaki, N., Poposki, J. A., Ogasawara, N., Oka, A., Klingler, A. I., Suh, L., Agrwal, A., Bai, J., Stevens, W. W., Peters, A. T., Grammer, L. C., Welch, K. C., Smith, S. S., Johnson, M., Radwan, A., Conley, D. B., Schleimer, R. P., Kern, R. C., …, & Kato, A. (2026). Heterogeneity and clinical relevance of group 2 innate lymphoid cells subsets in nasal polyps. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2026.03.021
Vancouver
Kidoguchi M, Iwasaki N, Poposki JA, Ogasawara N, Oka A, Klingler AI, et al. Heterogeneity and clinical relevance of group 2 innate lymphoid cells subsets in nasal polyps. Journal of Allergy and Clinical Immunology. 2026. doi:10.1016/j.jaci.2026.03.021
BibTeX
@article{Kidoguchi2026,
author = {Kidoguchi, Masanori and Iwasaki, Naruhito and Poposki, Julie A and Ogasawara, Noriko and Oka, Aiko and Klingler, Aiko I and Suh, Lydia and Agrwal, Aditi and Bai, Junqin and Stevens, Whitney W and Peters, Anju T and Grammer, Leslie C and Welch, Kevin C and Smith, Stephanie S and Johnson, Micah and Radwan, Amr and Conley, David B and Schleimer, Robert P and Kern, Robert C and Tan, Bruce K and Okano, Mitsuhiro and Fujieda, Shigeharu and Kato, Atsushi},
title = {Heterogeneity and clinical relevance of group 2 innate lymphoid cells subsets in nasal polyps},
journal = {Journal of Allergy and Clinical Immunology},
year = {2026},
doi = {10.1016/j.jaci.2026.03.021}
}
EUVIMED